Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06164795

Sequential Therapies After Osteoanabolic Treatment

Conditions: Osteoporosis, Postmenopausal

Sex: Female

Ages: 50 Years – 85 Years

Healthy volunteers: No

Enrollment: 150

Sponsor: 424 General Military Hospital

Location: 251 Airforce & VA General Hospital Athens

Summary

12-month prospective, open-label, multicenter, international, observational study evaluating sequential treatments after osteoanabolics

Eligibility Criteria

Inclusion Criteria: • Postmenopausal women treated with severe osteoporosis completing their course with romosozumab or teriparatide Exclusion Criteria: * a bone disease other than postmenopausal osteoporosis * use of medications other than romosozumab or teriparatide affecting bone metabolism during the last 12 months before entering the study * creatinine clearance \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06164795). StuddyBuddy aggregates publicly available trial information.